For example, Ushijima et al. demonstrated that ANGPTL4 is a genetically and epigenetically inactivated secreted tumour suppressor, and in gastric cancers ANGPTL4 suppresses in vivo tumorigenesis and angiogenesis through the ERK pathway [23]. This evidence concerns the gene ANGPTL4 and gastric cancer.